MONTREAL, April 21, 2022 (GLOBE NEWSWIRE) — RELEVIUM TECHNOLOGIES INC. (TSX.V: “RLV“, OTCQB:”RLLVF” and Frankfurt: 6BX“) (the “Companyor Relevium”), is pleased to provide an update on operations and continuous disclosure matters.


On December 16, 2021, the Company announced that it had delivered 127.5 million medical-grade nitrile gloves, representing 100% of the first of two PPE contracts the Company had entered into for a total value of $11 million THAT.

On January 25 and April 5 of this year, the Company delivered C$1 million and C$1.3 million, respectively, out of a total C$5 million of the second of two PPE contracts announced for the first time. on December 16, 2021. The balance of the second contract, totaling approximately C$2.7 million, is expected to be delivered by the end of April 2022.


As noted in previous press releases, the Company was unable to file its annual statements for the year ended June 30, 2021, as well as subsequent interim financial reports due to matters beyond the control of the Company. Company.

On November 1, 2021, the Company requested and received a management cease trade order (“MCTO”) regarding the late filing of its annual financial statements for the year ended June 30, 2021, including the report related management, and CEO and CFO certifications. Due to the fact that the audit process has not yet been completed, the securities regulator has imposed a full cease trade order (“CTO”) against the Company until that its continuous disclosure obligations are met. The CTO is expected to be lifted once the company completes the filing of its overdue financial statements and associated MD&A and CEO and CFO certifications.

Relevium’s management is working on replacing its current auditors and has accepted a proposal for services provided by Richter Accounting (“Richter”) as the Company’s new auditors. The Company will now go through the formal process of finalizing the change of auditor, including completing the required documentation on to reflect the proposed change. Management expects the audit work to begin immediately.

Aurelio Useche, CEO of Relevium said: “Like our shareholders, we have been extremely frustrated by the situation relating to the delays in completing last year’s audit, which have placed Relevium in the unfortunate default situation in which it finds itself. While these events are beyond our control, we at Relevium take this opportunity to apologize to our shareholders and reaffirm our commitment to complete the annual audit, file outstanding intermediaries and regulate disclosure obligations of the company so that it can resume normal trading in its shares.


On January 10, 2022, the TSX Venture Exchange (the “Exchange”) halted trading in the Company’s shares until the Company completes certain filings with the Exchange. The Company has been working to finalize these filings to resolve them so that the Exchange can remove the trading halt, which is expected to be completed within the next three weeks.

No more the TSX Business To exchange neither his Regulatory Services Vendor (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this Release.

About Relevium Technologies

Relevium Technologies Inc.., is a publicly traded company, focused on wellness and international sourcing, logistics and delivery of PPE in the North American market. Using trusted vendors and vendors and integrating a comprehensive, state-of-the-art supply chain, artificial intelligence and blockchain technology, enables a highly secure and compliant platform for the delivery of PPE equipment to governments, hospitals, foundations and various institutions.

Caution Regarding Forward-Looking Statements
This release contains certain statements and information that may constitute forward-looking information within the meaning of applicable Canadian securities laws. All statements in this press release, other than statements of historical facts, including statements regarding future estimates, plans, goals, assumptions or expectations of future performance, including satisfaction of supply in gloves under supply agreements and the timing thereof, the impact of the supply agreements disclosed herein on the Company’s financial results, the Company’s timing and ability to complete the filing of current financial statements, MD&A and certifications and to rescind the OTC, as well as the timing and completion of Exchange filings and removal of trading halts, are forward-looking statements and contain forward-looking information. Generally, forward-looking statements and information can be identified by the use of forward-looking terminology such as “intends” or “expects”, or variations of such words and phrases or statements that certain actions, events or “may”, “could”, “should”, “would” or “would” results.

Forward-looking statements are based on certain material assumptions and analyzes made by the Company and the opinions and estimates of management as of the date of this press release, including the Company’s ability to (i) complete the supply of gloves in in connection with the supply agreements, (ii) complete the necessary documents to cancel the CTO and lift the trading halt, (iii) successfully execute its business plans, (iv) maintain its expenses, (v) navigate the COVID-19 pandemic in a manner consistent with or better than its capacity and response to date. A description of additional risk factors that could cause actual results to differ materially from the forward-looking information is available in the Company’s disclosure documents on the SEDAR website at

These forward-looking statements are subject to known and unknown risks, uncertainties and other factors that could cause the actual results, level of activity, performance or achievements of the Company to be materially different from those expressed or implied by such forward-looking statements or information. Although the Company’s management has attempted to identify important factors that could cause actual results to differ materially from those contained in the forward-looking statements or information, there may be other factors that cause the results are not those anticipated, estimated or intended. . There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements and forward-looking information. Readers are cautioned that reliance on this information may not be appropriate for other purposes. The Company does not undertake to update any forward-looking statements, forward-looking information or financial outlook which are incorporated by reference herein, except in accordance with applicable securities laws. We are looking for a safe harbor.

On behalf of the Board of Directors


Aurelio Useche
President and CEO
For more information on this press release: Tel: +1.888.528.8687
E-mail: [email protected]
Like us on facebook
Follow us on twitter
Follow us on LinkedIn